Christopher Trevisani

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma

Deepak Bararia, Johannes Adrian Hildebrand, Sebastian Stolz et al. · Cell Reports · 2020 · 77 citations · Full text

Medicine, Immunology, Oncology +17

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Steven M. Horwitz, Ajit J. Nirmal, Jahan Rahman et al. · Nature Medicine · 2024 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

The effect of marathon running on carnitine metabolism and on some aspects of muscle mitochondrial activities and antioxidant mechanisms

Mehrengise Cooper, Jonathan D. G. Jones, R. H. T. Edwards et al. · Journal of Sports Sciences · 1986 · 41 citations

Life Sciences, Physiology, Sports Medicine +15

Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1

Wenchao Wu, Geoffrey M. Nelson, Raphael Koch et al. · Blood · 2021 · 36 citations · Full text

Life Sciences, Immunology, Oncology +10

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions

Noriaki Yoshida, Kay Shigemori, Nicholas L. Donaldson et al. · Blood · 2020 · 34 citations · Full text

Life Sciences, Genetics, Immunology +7